Over-expression of FGF2 in AD patients repairs spatial learning, long-term potentiation, and neurogenesis, likely mediated by FGFR1-activated boosts in the OX-2 membrane glycoprotein (CD200). Here, CD200 is linked to Alzheimer disease.